Financials
- Market Capitalization 2.89 B
- Employee 67
- Founded 2016
- CEO N/A
- Website www.enliventherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00CP3BDD4
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-8.42
市销率
-8 232.35
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1661 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 26.85 USD | -2.29% | -3.14% | -19.18% | +83.90% | 2.99 B USD | ||
| 1676 | DNLI Denali Therapeutics Inc. - Common Stock | 18.40 USD | -2.90% | -2.90% | -12.42% | +13.79% | 2.94 B USD | ||
| 1696 | RCUS Arcus Biosciences, Inc. Common Stock | 22.49 USD | -7.60% | -6.02% | -5.94% | +43.34% | 2.86 B USD | ||
| 1698 | DYN Dyne Therapeutics, Inc. - Common Stock | 15.30 USD | -4.14% | -0.65% | -17.39% | -34.64% | 2.86 B USD |